Sponsored Article
Sponsored Article

Novonesis is a world leader in biosolutions, which was formed from the merger of Novozymes and Chr. Hansen in 2024.
This merger created a leading global biosolutions company that specialises in the developing and production of enzymes, microorganisms, and probiotics for a range of industries including agriculture.
Novozymes was a global leader in developing biological solutions, delivering innovative feed enzymes that have been developed to meet today’s challenges in global livestock production.
For 25 years, Novozymes and dsm-firmenich worked together in the feed enzyme alliance combining the marketing and technical expertise to develop a range of enzymes for pig and poultry feeds.
Earlier this year, Novonesis acquired the feed alliance portfolio along with key technical and commercial expertise from dsm-firmenich, enabling the company to bring these innovative solutions directly to customers.
Novonesis will focus on combining enzymes and probiotics to enable pig and poultry producers to improve performance, health, welfare and reduce production costs as well as continuing to support monogastric production of the future through extensive research and development.
The demands placed on pig and poultry producers today is increasingly complex; driven by rising welfare standards, economic pressures, environmental regulations, and evolving customer expectations.
Feed represents a sizeable portion of production expenses; accounting for up to 70% of the total cost.
This prompts producers to devise strategies to optimise feed costs whilst maximising the nutrient availability in their ingredients.
Enzymes and microbes have emerged as vital solutions to enhance the availability and absorption of essential nutrients and help optimise costs.
Modern day enzymes and microbes play a crucial role in today’s animal production.
Traditional enzymes, including phytase and carbohydrase have become fundamental in pig and poultry production over the last decade, significantly contributing to the overall health and productivity of these animals.
As technology and our understanding of anti-nutritional factors continues to advance, Novonesis helps customers analyse their feed ingredients and develop tailored enzyme and nutritional strategies that optimise dose levels and feed matrix values for maximum performance and profitability.
As the benefits of enzymes in monogastric feed become increasingly clear, new complementary innovations - like proteases and our novel muramidase - are helping unlock greater feed efficiency, gastrointestinal functionality, and animal performance.
Enzymes are at the forefront of precision nutrition.
These powerful biosolutions help unlock more nutrients from feed ingredients - ensuring pigs and poultry receive a balanced, nutrient-rich diet that boosts health, improves productivity, and enhances meat and egg quality, while supporting sustainability and animal welfare.
In intensive production systems, maintaining animal health can be a challenge.
Building a strong microbiome and balanced digestion is key to helping animals unlock the full nutritional value of their feed and perform at their best.
Novonesis is dedicated to partnering with producers to develop innovative enzyme solutions and nutritional strategies that overcome production challenges and drive consistent, high-performing results in pig and poultry operations.
Our enzyme and probiotic solutions - including Balancius and our comprehensive range of Phytase, Carbohydrase, and Protease enzymes for poultry - work together to enhance gut health, nutrient utilisation, and overall productivity.
If you would like to talk about how Novonesis’ innovative solutions can help with your pig or poultry business, please contact your local representatives:
Alec Perrott: [email protected]
Jackie Redfearn: [email protected]
Sponsored Article
